Overview Financials News + Filings
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Soul Biotechnology Corp
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/05/2022 |
8-K
| Quarterly results |
| 02/10/2022 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...|
Docs:
|
"Entity Details",
"DEFINITIVE SHARE EXCHANGE AGREEMENT This Definitive Share Exchange Agreement , dated as of February 10, 2022, is between MySpray Therapeutics Inc. , a Saskatchewan, Canadian corporation located at Drawer 188, 36 Fourth Avenue North, Yorkton, Saskatchewan, Canada, S3N 2V7, Nichol Martinuik and Rachel Martinuik , the sole officers, directors, and shareholders of MySpray, with addresses at 125 Railway Avenue East, Canora, Saskatchewan, Canada, S0A0L0, Adorbs Inc. , located at 234 E. Beech St. Long Beach, New York 11561, Qatar Consulting Inc. & Company , Broadway Creative Consultants Corp. , a Saskatchewan, Canada corporation, and David Lazar , as the sole officer and director of ADOB and as the managing member of Activist Investing LLC . Collectively, Martinuik, MySpray, ADOB, R. Martinuik, Q...",
"PROMISSORY NOTE",
"CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Form 8-K of our report dated February 10, 2022, relating to the financial statements of Interactive MySpray Therapeutics, Inc. as of December 31, 2020 and 2019 and to all references to our firm included in this Registration Statement. Certified Public Accountants Lakewood, CO February 10, 2022" |
|
| 04/15/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|